Abbisko Cayman Limited (HKG:2256)
Hong Kong
· Delayed Price · Currency is HKD 12.85
+0.98 (8.26%)
Mar 10, 2026, 1:15 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 7.98 billion as of March 9, 2026. Its market cap has increased by 155.79% in one year.
Market Cap
7.98B
Enterprise Value
5.66B
Revenue
681.17M
Ranking
n/a
PE Ratio
120.61
Stock Price
12.85
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 7.98B, a decrease of -8.38%. That is a compound annual growth rate of -1.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 7.98B | -8.76% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lepu Biopharma | 7.92B |
| Alphamab Oncology | 7.60B |
| CK Life Sciences Int'l., (Holdings) | 7.59B |
| CStone Pharmaceuticals | 9.79B |
| Shanghai Haohai Biological Technology | 9.96B |
| HBM Holdings | 10.08B |
| CARsgen Therapeutics Holdings | 6.04B |
| Nanjing Leads Biolabs | 10.71B |